Novavax, Inc (NASDAQ:NVAX) shares, rose in value on Wednesday, March 26, with the stock price down by -2.25% to the previous day’s close as strong demand from buyers drove the stock to $7.39.
Actively observing the price movement in the last trading, the stock closed the session at $7.56, falling within a range of $7.25 and $7.565. The value of beta (5-year monthly) was 2.91. Referring to stock’s 52-week performance, its high was $23.86, and the low was $3.81. On the whole, NVAX has fluctuated by 3.07% over the past month.
With the market capitalization of Novavax, Inc currently standing at about $1.19 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 503.95M, with a low estimate of 31.9M and a high estimate of 106.4M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 67.7M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that NVAX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of NVAX currently trading nearly -6.22% and -9.83% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.84, while the 7-day volatility ratio is showing 3.29% which for the 30-day chart, stands at 6.90%. Furthermore, Novavax, Inc (NVAX)’s beta value is 3.11, and its average true range (ATR) is 0.46.
A comparison of Novavax, Inc (NVAX) with its peers suggests the former has fared considerably weaker in the market. NVAX showed an intraday change of -2.25% in last session, and over the past year, it grew by 57.23%%.
Data on historical trading for Novavax, Inc (NASDAQ:NVAX) indicates that the trading volumes over the past 10 days have averaged 3.28 and over the past 3 months, they’ve averaged 4.27 million. According to company’s latest data on outstanding shares, there are 160.42 million shares outstanding.
Nearly 8.87% of Novavax, Inc’s shares belong to company insiders and institutional investors own 59.79% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 37.55 million shares as on 2025-03-14, resulting in a short ratio of 7.71. According to the data, the short interest in Novavax, Inc (NVAX) stood at 2909.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 35.45 million. The stock has fallen by -8.08% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the NVAX stock heading into the next quarter.
